G0333
Pharmacy dispensing fee for inhalation drug(s); initial 30-day supply as a beneficiary
- Release
- October 2026
- Effective
Official Coding Notes
Reproduced verbatim from the October 2026 HCPCS Level II files.
Note
SECTION 303(e)(2) OF THE MMA IMPLEMENTS A SUPPLYING FEE FOR IMMUNOSUPPRESSIVE DRUGS, ORAL ANTI-CANCER CHEMOTHERAPEUTIC DRUGS, AND ANTI-EMETIC DRUGS USED AS PART OF AN ANTI-CANCER CHEMOTHERAPEUTIC REGIMEN.
Version History
How G0333 appears in each release imported from the official files, newest first.
-
October 2026 Effective
CurrentPharmacy dispensing fee for inhalation drug(s); initial 30-day supply as a beneficiary
-
July 2026 Effective
UnchangedPharmacy dispensing fee for inhalation drug(s); initial 30-day supply as a beneficiary
-
April 2026 Effective
UnchangedPharmacy dispensing fee for inhalation drug(s); initial 30-day supply as a beneficiary
-
January 2026 Effective
UnchangedPharmacy dispensing fee for inhalation drug(s); initial 30-day supply as a beneficiary
Data Source
Code information on this page is derived from the October 2026 HCPCS Level II files published by CMS.
- Release
- October 2026
- Effective
- Source file
- october-2026-alpha-numeric-hcpcs-file.zip
Official HCPCS Level II source files (opens in a new tab)
MedCodeSearch is an independent reference service and is not affiliated with CMS, CDC, or the U.S. government.
Look up another code
Search ICD-10-CM, ICD-10-PCS and HCPCS Level II by code or description.